Cargando…
Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
SIMPLE SUMMARY: Although multiple meta-analyses on active specific immunotherapy treatment for glioblastoma multiforme (GBM) have demonstrated a significant prolongation of overall survival, no single research group has succeeded in demonstrating the efficacy of this type of treatment in a prospecti...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796083/ https://www.ncbi.nlm.nih.gov/pubmed/33374196 http://dx.doi.org/10.3390/cancers13010032 |